Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06859216 · ClinicalTrials.gov registry record · NA
Evaluating AI-Generated Plain Language Summaries on Patient Comprehension of Ophthalmology Notes Among English-Speaking Patients
A NA study of Large Language Model and Ophthalmic Disease, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 460
- Enrollment target
- 1
- Study location
NCT06859216: Recruiting NA study of Large Language Model and Ophthalmic Disease, sponsored by University of California, Los Angeles.
NCT06859216 is a NA study of Large Language Model and Ophthalmic Disease that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 460 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06859216, a NA study of Large Language Model and Ophthalmic Disease, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 460 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial is testing whether plain language summaries made by artificial intelligence help people understand their eye doctor's notes better. Adults receiving eye care at the Jules Stein Eye Institute will get either the usual medical notes or a note with the addition of an AI-generated summary that explains the information in simple, everyday words. Participants will then answer a short survey and receive a follow-up call to share how clear the information was, how well they understood their diagnosis and treatment, and whether they feel more confident about their care. The goal is to find out if these plain language summaries can make it easier for people to understand their eye care and improve communication between patients and health care providers.
Primary Outcome
Mean score on a 5-point scale assessing participants' understanding of their ophthalmology visit notes (diagnosis, treatment plan, follow-up instructions) immediately after the clinic visit. Higher scores indicate better comprehension.
Conditions Studied
Interventions
- BEHAVIORAL AI-Generated Plain Language Summaries
Study Locations (1)
California
- UCLA - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 460 participants |
| Start Date | 2025-03-01 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What NCT06859216 shows while recruiting
NCT06859216 is an interventional study that assigns participants to a tested intervention. The registered 460 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower).
The record links to 3 conditions, with Large Language Model appearing as the primary indexed condition, and to 1 intervention - of which AI-Generated Plain Language Summaries is the first listed.
NCT06859216 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06859216 about?
NCT06859216 is a clinical study titled "Evaluating AI-Generated Plain Language Summaries on Patient Comprehension of Ophthalmology Notes Among English-Speaking Patients". This clinical trial is testing whether plain language summaries made by artificial intelligence help people understand their eye doctor's notes better. Adults receiving eye care at the Jules Stein Eye Institute will get either the usual medical notes or a note with the addition of an AI-generated su...
What is the current status of trial NCT06859216?
This trial is currently recruiting. It is a NA study. The enrollment target is 460 participants. The study started on 2025-03-01. Estimated completion is 2026-06-01.
What conditions does trial NCT06859216 study?
This clinical trial studies the following conditions: Large Language Model, Ophthalmic Disease, Artifical Intelligence.
What interventions are being tested in trial NCT06859216?
The interventions under investigation include: AI-Generated Plain Language Summaries (BEHAVIORAL).
Who is sponsoring clinical trial NCT06859216?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06859216 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Large Language Model
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06859216's enrollment target sits among peer trials
460 222nd of 2000 higher than 1,777 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02977780 · 460 participants · Phase 2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- NCT03427736 · 460 participants
Anesthetics and Analgesics in Children
- NCT03819933 · 460 participants · NA
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
- NCT04621279 · 460 participants
Cool Prime Comparative Effectiveness Study for Mild HIE
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI